Back to search

University of British Columbia

Examining experiences of serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (IOAT)

Abstract

dc:description

Background: Mental health and substance use disorder (SUD) are often concurrent and comorbid disorders that share several causal factors. This study aims to provide evidence of factors that impact participant reported experiences of serious depression and serious anxiety among a cohort of individuals receiving injectable opioid agonist treatment (iOAT). Methods: This study utilized data from a longitudinal retrospective cohort study of individuals receiving iOAT (i.e. diacetylmorphine and hydromorphone) in Vancouver, Canada from 2016-2018. The primary outcomes of serious depression and serious anxiety were ascertained via participant self-report in the psychiatric domain of the European Addiction Severity Index (EuropASI). Analyses utilized Generalized Linear Mixed Models with random intercepts and Penalized Quasi-Likelihood (GLMMPQL) method of inference to examine associations between several factors and the outcomes of depression and anxiety. Results: Of the 131 participants included in the analyses, the average age was 49.04 years (SD = 9.32), 31% self-identified as female, 30% self-identified as Indigenous (Métis, Inuit, First Nations), 55% reported a chronic medical problem, and mean number of reported days using illicit opioids was 5.97 days (SD = 7.72). Adjusted analysis of serious depression demonstrated significant associations between poorer physical health, recent illicit opioid use, emotional abuse, and free time spent alone. Likewise, adjusted analysis of serious anxiety identified significant associations with age, recent illicit benzodiazepine use, poorer physical health, and social problems. Conclusion: Several factors were identified as associated with the outcomes of serious depression and serious anxiety. As iOAT care continues to expand, there is a clear need for person-centered care (PCC) initiatives that can consider the unique needs of clients experiencing depression and anxiety while providing integrated psychotherapeutic and pharmacological supports.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Population and Public Health
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Magel, Tianna
Contributors dc:contributor
  • Oviedo-Joekes, Eugenia

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/86728

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Magel, Tianna. Examining experiences of serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (IOAT). master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/86728